Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

JNJ 93.39 -1.37 (-1.45%)
price chart
Johnson & Johnson to open life science centres
Johnson & Johnson is to open four life science “innovation centres” as it decentralises decisions on investment and partnerships to boost productivity.
Johnson & Johnson sets up SF center  San Francisco Chronicle
Johnson & Johnson to open 'innovation centers' in Bay Area, globally (blog)
J.&J. Names Outsider to Run Its Troubled Consumer Unit
Johnson & Johnson named an outsider on Thursday to fill a top leadership role overseeing its troubled consumer health unit, a break from the company's longstanding tradition of promoting executives from within.
J&J Recruits Bayer Executive  Wall Street Journal
Johnson & Johnson Hires Former Bayer Exec To Combat Mounting Porblems  ValueWalk
Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to ...
Johnson & Johnson's top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers for a teenager suing the drugmaker said in a court filing.
Johnson & Johnson Launches Be Vital Challenge to Reward College Student ...
NEW BRUNSWICK, N.J., Sept. 18, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) is launching a challenge to reward college student organizations for their effort in taking care of the world we share.
Lawyer Fights $10 Million Fee For "Cosmetic" Johnson And Johnson Settlement
Since this is a so-called derivative action filed on behalf of Johnson & Johnson itself, the settlement would actually cost their clients $10 million, on top of the millions of dollars the medical-products giant has already paid the government to ...
Johnson & Johnson Report: 54% of Hospitals Say Green Attributes Important in ...
More than one-third (35 percent) of hospitals surveyed switched suppliers to gain access to sustainable health-care products, according to a new report by Johnson & Johnson that finds hospitals are placing greater emphasis on “green” products used in ...
Future Impact of Environmental Scorecards, Hospital Global Purchasing ... (press release)
J&J Settles Risperdal Lawsuit on Opening Day of Trial
Sept. 10 (Bloomberg) -- Johnson & Johnson settled a lawsuit on the first day of a trial over claims its antipsychotic drug Risperdal caused a male plaintiff to grow breast tissue, one of his lawyers told a state judge in Philadelphia.
J&J Sees Male Breasts And Quickly Settles Risperdal Suit  Forbes
J&J Settles Pa. Risperdal Lawsuit On Opening Day of Trial  Law360 (subscription)
Johnson & Johnson-Tied Company Illegally Tested Products On Humans With ...
FORTUNE -- On Nov. 16, 2011, Georgia Baddley, a 70-year-old woman living near Salt Lake City, received a shocking call from a special agent at the U.S.
Johnson & Johnson wins challenge to Abbott antibodies patents
Johnson & Johnson won its challenge to two Abbott Laboratories patents on antibodies that help curb the effects of the painful skin disease psoriasis.
Jury Finds For J&J Unit In Row Over Abbott Antibody Patents  Law360 (subscription)
Transvaginal Mesh Lawsuit Alleges Johnson & Johnson's Gynecare Gynemesh ...
BOSTON--(BUSINESS WIRE)--Gilman Law LLP has filed a transvaginal mesh lawsuit on behalf of a woman from Missouri who suffered severe complications, including the need for two additional surgeries, following implantation of Johnson & Johnson's ...